WHO issues global guideline on the use of GLP-1 medicines in treating obesity

<p>To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health Organization (WHO) has released its <a href=”https://app.magicapp.org/#/guideline/LrRxrL”>first guideline</a> on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease.</p><p>Obesity affects people in every country and was associated with 3.7 million deaths worldwide in […]

WHO releases new guidelines around weight-loss drugs amid obesity epidemic | The World | ABC NEWS

The World Health Organisation has released guidelines recommending GLP-1-type medications as long-term treatments for obesity, issuing a global call to its member states to ensure its management is available, affordable and sustainable universally. Dr Terri-Lynne South, a dietician and chair of the RACGP Obesity Management Group, tells The World how significant this endorsement is to […]

What are GLP-1 therapies?

GLP-1 therapies are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can even lower the risk of early death in people with type 2 diabetes. These must be prescribed by your health care specialist and require close follow-ups. People living with obesity, […]